Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05569005 · ClinicalTrials.gov registry record · NA
Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.
A NA study, sponsored by Philip Morris Products S.A..
- Terminated
- Registry status
- NA
- Development phase
- 715
- Enrollment target
NCT05569005: Clinical Trial NA study, sponsored by Philip Morris Products S.A..
NCT05569005 is a NA study that was terminated before completion, run by Philip Morris Products S.A.. The registered enrollment target is 715 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05569005, a NA study, was terminated before completion, sponsored by Philip Morris Products S.A..
- TERMINATED
- Registry status
- NA
- Development phase
- 715 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the slowing of the disease progression including the improvement of Chronic Obstructive Pulmonary Disease (COPD) symptoms in smoking subjects with mild to moderate COPD and a history of chronic bronchitis symptoms (sputum and cough) who switch to the Tobacco Heating System (THS) as compared to those who continue to smoke cigarettes.
Primary Outcome
Disease progression will be assessed by measuring Forced Expiratory Volume in 1 second (FEV1), post-bronchodilator
Interventions
- OTHER Cigarette
- OTHER Smoking Abstinence
- OTHER THS use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2022-12-16 |
| Est. Completion | 2024-09-13 |
| Phase | NA |
Why NCT05569005 stopped before completion
NCT05569005 is an interventional study that assigns participants to a tested intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 3 interventions - of which Cigarette is the first listed.
NCT05569005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05569005 about?
NCT05569005 is a clinical study titled "Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.". The purpose of this study is to demonstrate the slowing of the disease progression including the improvement of Chronic Obstructive Pulmonary Disease (COPD) symptoms in smoking subjects with mild to moderate COPD and a history of chronic bronchitis symptoms (sputum and cough) who switch to the Tobac...
What is the current status of trial NCT05569005?
This trial is currently terminated. It is a NA study. The enrollment target is 715 participants. The study started on 2022-12-16. Estimated completion is 2024-09-13.
What interventions are being tested in trial NCT05569005?
The interventions under investigation include: Cigarette (OTHER), Smoking Abstinence (OTHER), THS use (OTHER).
Who is sponsoring clinical trial NCT05569005?
This trial is sponsored by Philip Morris Products S.A., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05569005's enrollment target sits among peer trials
715 147th of 2000 higher than 1,854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI